13F Holdings
中文EN

BIOF BLUE BIOFUELS, INC.

Industrial Organic Chemicals · OTC · SEC CIK 1549145 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY-21.1%
TTM EPS YoY-18.2%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE—
ROA-288.0%
ROIC (approx.)—
Asset turnover—

Leverage & solvency

Liabilities / assets436.2%
Debt / equity—
Current ratio0.01x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.35x
Accruals ratio-187.8%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue—————
R&D expense$2.31M$2.33M$1.85M$2.35M$1.10M
SG&A expense$1.41M$1.73M$1.34M$1.54M$1.03M
Operating income-$3.72M-$4.06M-$3.19M-$3.93M-$2.17M
Net income-$2.87M-$1.42M-$3.06M-$3.96M-$2.14M
EBITDA-$3.57M-$3.94M-$3.07M-$3.79M-$2.04M
EPS (basic)-0.01-0.01-0.01-0.01-0.01
EPS (diluted)-0.01-0.01-0.01——
Weighted avg. shares (diluted)312.19M303.85M299.95M——
Balance sheet
Cash & equivalents$65,200$48,797$41,008$211,901$1.16M
Current assets$76,751$81,286$76,758$255,020$1.21M
PP&E, net$555,109$539,648$587,308$420,115$377,645
Intangibles$61,098————
Total assets$1.41M$1.39M$1.03M$1.11M$1.84M
Current liabilities$2.98M$2.21M$1.50M$638,721$496,161
Total liabilities$5.11M$4.24M$4.59M$3.46M$3.23M
Shareholders' equity-$3.71M-$2.85M-$3.56M-$2.36M-$1.40M
Shares outstanding317.87M307.96M302.75M289.94M274.00M
Cash flow statement
Operating cash flow-$845,002-$1.00M-$1.60M-$2.04M-$2.47M
Capital expenditure$68,898$71,138$287,828$138,170$216,390
Free cash flow-$913,900-$1.07M-$1.89M-$2.17M-$2.68M
Investing cash flow-$137,345-$115,791-$320,505-$205,520-$233,132
Financing cash flow$998,750$1.13M$1.75M$1.29M$3.58M
Depreciation & amortization$145,852$118,798$119,476$138,464$131,715
Stock-based compensation$956,610$1.65M$637,028$136,550$120,152

Free plan shows the latest 5 periods; Pro shows all 12 🔒

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.